Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

334
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
334
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

77
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
77
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.5K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.5K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

310
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
310
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.8K
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic design of auxotrophic strains and media conditions to probe metabolic functions in E. coli.

PLoS computational biology·2026
Same author

BindPred: a framework for predicting protein-protein binding affinity from language model embeddings.

Bioinformatics (Oxford, England)·2026
Same author

MechFind: a computational framework for de novo prediction of enzyme mechanisms.

Nature communications·2026
Same author

High yield production of 3-hydroxypropionic acid using Issatchenkia orientalis.

Nature communications·2026
Same author

Building an expanded bio-based economy through synthetic biology.

Biotechnology advances·2025
Same author

Metabolic flux and resource balance in the oleaginous yeast Rhodotorula toruloides.

Metabolic engineering·2025

Related Experiment Video

Updated: Mar 21, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.5K

Personalized Kinetic Models for Predictive Healthcare.

Anupam Chowdhury1, Costas D Maranas1

  • 1Department of Chemical Engineering, The Pennsylvania State University, University Park, PA 16802, USA.

Cell Systems
|May 3, 2016
PubMed
Summary

This study uses metabolomics data to create personalized models of metabolism. These models predict health and disease states by analyzing individual metabolic parameters.

Area of Science:

  • Biochemistry
  • Systems Biology
  • Computational Biology

Background:

  • Metabolomics provides a snapshot of an organism's metabolic state.
  • Kinetic models of metabolism can elucidate complex biological processes.
  • Personalized medicine requires understanding individual metabolic variations.

Purpose of the Study:

  • To develop individual-specific kinetic models of metabolism.
  • To utilize metabolomics data for model parameterization.
  • To predict medically relevant parameters for disease states and outcomes.

Main Methods:

  • Acquisition and analysis of metabolomics data.
  • Development and parameterization of individual-specific kinetic metabolic models.
  • Validation of model predictions against clinical data.

More Related Videos

Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training
09:57

Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training

Published on: January 18, 2021

4.7K
Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface
11:54

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface

Published on: May 8, 2021

5.3K

Related Experiment Videos

Last Updated: Mar 21, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.5K
Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training
09:57

Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training

Published on: January 18, 2021

4.7K
Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface
11:54

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface

Published on: May 8, 2021

5.3K

Main Results:

  • Successful parameterization of kinetic models using metabolomics data.
  • Demonstrated ability of models to predict disease-relevant metabolic parameters.
  • Identification of key metabolic pathways influencing individual health outcomes.

Conclusions:

  • Individual-specific kinetic metabolic models are feasible using metabolomics data.
  • These models offer a powerful tool for personalized health predictions.
  • This approach advances the understanding of metabolic underpinnings of disease.